Cyber-Care Enhances Telehealth Initiative With Acquisition of Home Workstation Product.

Business Editors/Health & Medical Writers

BOYNTON BEACH, Fla.--(BW HealthWire)--April 20, 2001

Cyber-Care, Inc. (Nasdaq:CYBR) today announced that it has reached an agreement with CardioCommand, Inc., Tampa, Florida, to purchase the CloseTouch(TM) COMPANION home workstation technology. The acquisition is valued at $3.2 million.

The CloseTouch COMPANION is an eighteen-pound portable workstation that will accommodate Cyber-Care's peripheral devices and will operate using a variety of telecommunication technologies including standard telephone lines and broadband telecommunication. CardioCommand agreed that it would adapt the CloseTouch COMPANION to operate Cyber-Care's proprietary software and operate on Cyber-Care's network. Under the agreement, the consideration will be held in escrow during the adaptation period. Adaptation will result in the CloseTouch COMPANION being compliant with Cyber-Care's previous Food and Drug Administration (FDA) clearance for Class II 510-k medical devices.

"We look forward to working closely with Cyber-Care to optimize the COMPANION as a fundamental platform for delivering telehealth service worldwide," said Maynard Ramsey, M.D, Ph.D., CardioCommand's chief executive and chief science and technical officer. "Cyber-Care's selection of our product further validates CardioCommand's efforts to create small, powerful and user-friendly third-generation home workstations."

With cardiovascular disease topping the nation's list of leading killers, Mike Lemnitzer, vice president of business development for Cyber-Care, expressed appreciation for CardioCommand's anticipated contributions to combating this illness through the collaboration. "The CloseTouch COMPANION further enhances the Electronic HouseCall(R) System and advances our telehealth initiatives to a whole new level," Lemnitzer said. "This agreement demonstrates how telemonitoring companies can effectively collaborate and adapt their products to Cyber-Care's proprietary software and networking capabilities."

Prior to joining CardioCommand, Dr. Ramsey was vice president of research and development at Critikon, a division of Johnson & Johnson (NYSE:JNJ). At the close of escrow, Dr. Ramsey will join the management team of Cyber-Care, Inc. Throughout the transaction, Raymond James & Associates, Inc. represented CardioCommand.

About Cyber-Care Inc.

Cyber-Care Inc., (Nasdaq:CYBR) is a network-based telehealth solutions company improving the delivery of care through its Internet-based technology. Cyber-Care creates a live, interactive community that incorporates all members of the care team in the delivery of the healthcare process, resulting in cost reduction and improvement in the quality of patient care. Utilizing patented technology for remote monitoring and real-time interactive communications between chronically ill patients and their providers, Cyber-Care's Electronic HouseCall System allows for effective and efficient data collection, case management and personal interaction. Headquartered in Boynton Beach, Fla., Cyber-Care also has physical, occupational and speech therapy businesses and an institutional pharmacy business. Visit Cyber-Care's Web site at www.cyber-care.net.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.